Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply

JAMA. 2015 Sep 15;314(11):1177-8. doi: 10.1001/jama.2015.9719.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amyloid beta-Peptides / analysis*
  • Apolipoprotein E4 / genetics*
  • Brain / pathology*
  • Cognitive Dysfunction / pathology*
  • Female
  • Humans
  • Male

Substances

  • Amyloid beta-Peptides
  • Apolipoprotein E4